Brind.

Pfizer announced a $6.7 billion deal to expand cannabinoid treatments, involving Arena Pharmaceuticals. Concurrently, OSRAM and Godox are leveraging market trends influenced by the International Energy Agency in Switzerland.

1 report, 0 independent Updated Jul 1

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

SpeculativeNo independent reporting found

Who's involved

What this event is mainly about

Pfizer Arena Pharmaceuticals Switzerland

Keep exploring

The entities involved

Pfizer
American multinational pharmaceutical and biotechnology corporation
- Medicus Pharma secured an ADC development deal with Pfizer and is advancing its SkinJect 005 study for FDA approval.Sat 00:01
- Major pharmaceutical companies licensed drug delivery technologies like Enhanze and Hypercon for various applications.Fri 16:54
Arena Pharmaceuticals
American biopharmaceutical company

Nothing else this week.
Switzerland
country in Central Europe
- A Federal Court upheld a ruling that judges in Switzerland were living together in breach of law.Fri 18:59
- Coca-Cola HBC, now based in Switzerland, faces attempts by Bochkari, mirroring Kremlin actions, to seize its subsidiaries.Fri 17:04

Coverage

Newest first; wire copies grouped

Jul 1Unknown outlet